| Location: | Maryland |
|---|---|
| Posted: | Feb 6, 2026 |
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Type of Contract: | Awards |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | 75N91026P00006 |
| Publication URL: | To access bid details, please log in. |
This is a Firm Fixed Price Purchase Order. The National Cancer Institute (NCI) awarded a purchase order to Ferox LLC to obtain a Bond Rx Controller for a clinical instrument (Leica Bond) Automated Immunohistochemistry stainer annual (1 year warranty included) and recommended Preventative Maintenance post-instrument relocation (with PM Kit included). The instrument will be used for validation of clinical IHC target markers for diagnostic and in some cases enrollment to NIH clinical trials. In the clinical research application, the Bond Rx instrument will be used for critical research in rare tumor identification and subsequent development of therapeutic mechanisms for patients undergoing treatments.

With GovernmentContracts, you can:
...Department/Ind. Agency DEPT OF DEFENSE Sub-tier DEFENSE HEALTH AGENCY (DHA) Office DEFENSE HEALTH...: ...
DEPT OF DEFENSE
Bid Due: 11/02/2026
...DEFENSE Sub-tier DEFENSE HEALTH AGENCY (DHA) Office DEFENSE HEALTH AGENCY Looking for contract ...
DEPT OF DEFENSE
Bid Due: 10/26/2026
...HT942523P0084 Related Notice Department/Ind. Agency DEPT OF DEFENSE Sub-tier DEFENSE HEALTH AGENCY (DHA...) ...
DEPT OF DEFENSE
Bid Due: 10/15/2026
...Department/Ind. Agency DEPT OF DEFENSE Sub-tier DEFENSE HEALTH AGENCY (DHA) Office DEFENSE HEALTH ...
DEPT OF DEFENSE
Bid Due: 10/23/2026